Billerica, Mass. — Quanterix Corporation has appointed Jason Faessler as chief financial officer, effective June 22.
Quanterix, a company focused on advancing biomarker breakthroughs from discovery to diagnostics, said Faessler brings finance leadership experience in the life science tools industry and will help support the company’s strategic growth plans.
“We are thrilled to welcome Jason to the Quanterix leadership team,” said Everett Cunningham, Chief Executive Officer of Quanterix. “His extensive track record within life science organizations makes him the ideal leader to support our ambitious growth objectives. Jason’s expertise in strategic financial and capital planning, operational excellence, and commercial support will be instrumental in advancing our mission.”
Faessler joins Quanterix from Bruker Corporation, where he served as senior vice president, leading global financial planning and analysis and the Americas Finance organization. His responsibilities included strategic planning, operational finance and capital decision-making.
Before Bruker, Faessler held senior finance leadership roles at PAREXEL, where he led the company’s Early- and Late-Phase Clinical divisions and helped drive growth and profitability across both businesses.
He also held senior financial management roles at EMC, now Dell, and Harvard Business Publishing.
“I am both excited and honored to join Quanterix at this pivotal moment in its journey,” Faessler adds. “The Company is uniquely positioned for growth with two leading scientific instrument platforms and an emerging diagnostics capability. Quanterix’s technology is enabling earlier disease detection and deeper insights into both research and clinical settings, helping to advance science and improve patient outcomes. I look forward to partnering with Everett and the leadership team to drive sustained value creation for our shareholders by capturing these opportunities.”
